The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA and alkaline phosphatase changes in the EORTC-1333 PEACE-3 study evaluating the addition of six cycles of radium 223 in metastatic castration-resistant prostate cancer (mCRPC) starting enzalutamide.
 
Ananya Choudhury
No Relationships to Disclose
 
Silke Gillessen
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); InnoMedica (Inst); Ipsen (Inst); LinkinVax (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); PeerVoice (Inst); Pfizer (Inst)
Speakers' Bureau - AdMeTech Foundation (Inst); ASCO GU (Inst); Avalere Health (Inst); EPG Health (Inst); ESMO; ESMO (Inst); Intellisphere (Inst); Medtoday Switzerland (Inst); Meister ConCept GmbH (Inst); Orikata (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Group for Clinical Cancer Research (SAKK) (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - Bayer; Gilead Sciences; Intellisphere; Johnson & Johnson/Janssen
Other Relationship - University of Applied Sciences and Arts of Southern Switzerland (SUPSI)
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; GlaxoSmithKline; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Sumitomo Dainippon Pharma Oncology; Tolmar
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; GlaxoSmithKline; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi; Sumitomo Dainippon Pharma Oncology; Tolmar
Research Funding - Abbvie (Inst); Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Point Therapeutics (Inst); Sanofi (Inst)
 
Enrique Gallardo Diaz
Honoraria - Advanced Accelerator Applications; AstraZeneca Spain; Bayer; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Ipsen; LEO Pharma; Pfizer; Recordati; Rovi; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Speakers' Bureau - Advanced Accelerator Applications; Bristol-Myers Squibb; Eisai; Ipsen; MSD Oncology; MSD Oncology; Sanofi/Aventis
Travel, Accommodations, Expenses - Bayer; Ipsen
 
Andrey Soares
Honoraria - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Janssen; Merck Serono; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Adium Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Adium Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Raymond McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche
 
Alejo Rodríguez-Vida
Honoraria - Astellas Oncology; AstraZeneca/UK; Bayer Health; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Pfizer
Travel, Accommodations, Expenses - Astellas Oncology; AstraZeneca/UK; Bayer Health; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Pfizer; Roche
 
Pedro Isaacsson Velho
Honoraria - Astellas Pharma; AstraZeneca/UK; Bayer; Janssen; Novartis
Speakers' Bureau - Astellas Oncology; AstraZeneca/UK; Bayer; BMS GmbH & Co. KG; Janssen; Merck; MSD; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Merck; MSD
 
Franco Nole
No Relationships to Disclose
 
Felipe Cruz
Honoraria - Astellas Oncology; Janssen
Travel, Accommodations, Expenses - BMS Brazil
 
Thierry Roumeguere
No Relationships to Disclose
 
Gedske Daugaard
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Bayer; Merck
 
Rosely Yamamura
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS Brazil (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Gilead Sciences (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Coralie Poncet
No Relationships to Disclose
 
Corneel Coens
No Relationships to Disclose
 
Beatrice Fournier
No Relationships to Disclose
 
Bertrand Tombal
Honoraria - AAA/Endocyte/Novartis; Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; Janssen; MSD Oncology; Myovant Sciences; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer/Astellas; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen
Research Funding - Ferring (Inst)
Expert Testimony - Steba Biotech
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi